Mesalamine Tablet, Delayed Release
Product Images NDC 72603-304

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Mesalamine (NDC 72603-304). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northstar Rxllc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

120scontainer (120scontainer)

Mesalamine Delayed-Release Tablets, USP 1.2 g per tablet, oral dosage form shown on a label for a 120-tablet bottle. The label includes storage instructions, pharmacist dispensing information, manufacturer details Northstar Rx LLC and Annora Pharma Pvt. Ltd., and a barcode. The product is indicated as Rx only and produced in India.*

FDA Label Image

Mesalaminedrtabsstructure (Mesalaminedrtabsstructure)

Chemical structure of mesalamine showing the molecular arrangement including hydroxyl, amino, and carboxyl functional groups attached to a benzene ring.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.